Biotech Intuition Transistor (https://transistor.fm) https://feeds.transistor.fm/biotech-intuition Biotech Intuition helps you understand the biotechnology developments that matter—without the noise. Each concise episode highlights the day’s most consequential clinical results, regulatory decisions, scientific advances, partnerships, financings, and industry developments. We explain what happened, why it matters, the important uncertainties, and what to watch next. Produced by SOZO Intuition, the biotechnology intelligence platform connecting companies, therapeutics, technologies, diseases, research, and industry news. Episodes are AI-narrated and reviewed against original sources. Sources and further reading are included in the show notes. 2026 SOZO Intuition Systems, Corp. 82e6538e-940a-53d2-8661-ee77b18720bb yes en Tue, 13 Oct 2026 06:35:39 -0700 Tue, 13 Oct 2026 06:36:19 -0700 https://img.transistorcdn.com/nXXSrumPLuXYtyCvMvRyDEVzaqvqHiwk3IiRyq69VAk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wZGRl/OGVlNDg2NjQ1MmUx/OTMyMjcxZmY3Zjdk/N2JiYS5qcGVn.jpg Biotech Intuition episodic SOZO Intution Biotech Intuition helps you understand the biotechnology developments that matter—without the noise. Each concise episode highlights the day’s most consequential clinical results, regulatory decisions, scientific advances, partnerships, financings, and industry developments. We explain what happened, why it matters, the important uncertainties, and what to watch next. Produced by SOZO Intuition, the biotechnology intelligence platform connecting companies, therapeutics, technologies, diseases, research, and industry news. Episodes are AI-narrated and reviewed against original sources. Sources and further reading are included in the show notes. Biotech Intuition helps you understand the biotechnology developments that matter—without the noise. biotechnology, pharmaceutical, life sciences SOZO Intuition Systems No No Biotech Daily - 13th October 2026 9 9 Biotech Daily - 13th October 2026 full 233df95e-72f8-4684-b7eb-f20f71596170 https://share.transistor.fm/s/a59c1bc5 This digest covers key developments from BioNTech, Samsung Biologics, Johnson & Johnson, and Formycon, including Phase III readouts, a cross-border tender offer, and regulatory acceptances, alongside broader coverage across the sector. 

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> This digest covers key developments from BioNTech, Samsung Biologics, Johnson & Johnson, and Formycon, including Phase III readouts, a cross-border tender offer, and regulatory acceptances, alongside broader coverage across the sector. 

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Tue, 13 Oct 2026 06:35:37 -0700 SOZO Intution SOZO Intution 394 This digest covers key developments from BioNTech, Samsung Biologics, Johnson & Johnson, and Formycon, including Phase III readouts, a cross-border tender offer, and regulatory acceptances, alongside broader coverage across the sector. 

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 9th October 2026 8 8 Biotech Daily - 9th October 2026 full 37d27192-27c8-4d37-8ed3-ab6f2f46fe65 https://share.transistor.fm/s/eeb376cc Featuring Bristol Myers Squibb, Roche, Viatris and Pacira Pharmaceuticals

Primary themes: Phase 3 clinical readouts, first-in-setting FDA approvals, and a non-opioid pain acquisition.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Featuring Bristol Myers Squibb, Roche, Viatris and Pacira Pharmaceuticals

Primary themes: Phase 3 clinical readouts, first-in-setting FDA approvals, and a non-opioid pain acquisition.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Fri, 09 Oct 2026 06:43:10 -0700 SOZO Intution SOZO Intution 406 Featuring Bristol Myers Squibb, Roche, Viatris and Pacira Pharmaceuticals

Primary themes: Phase 3 clinical readouts, first-in-setting FDA approvals, and a non-opioid pain acquisition.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 8th October 2026 7 7 Biotech Daily - 8th October 2026 full 14616f9c-abcd-4775-92b6-16c6d2c8f241 https://share.transistor.fm/s/7566f879 Featuring Pfizer, Addex Therapeutics, Neurosterix and Microba Life Sciences

Primary themes: FDA regulatory approval, clinical product advancement, diagnostic product launch.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Featuring Pfizer, Addex Therapeutics, Neurosterix and Microba Life Sciences

Primary themes: FDA regulatory approval, clinical product advancement, diagnostic product launch.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Thu, 08 Oct 2026 07:24:27 -0700 SOZO Intution SOZO Intution 371 Featuring Pfizer, Addex Therapeutics, Neurosterix and Microba Life Sciences

Primary themes: FDA regulatory approval, clinical product advancement, diagnostic product launch.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 7th October 2026 6 6 Biotech Daily - 7th October 2026 full 993861ac-01f0-43c6-88c1-dede86e1c2ed https://share.transistor.fm/s/a4803ec9 Featuring Capricor Therapeutics, Caribou Biosciences, Repligen and Arrowhead Pharmaceuticals.

Primary themes: clinical trial results, business development and venture financing.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Featuring Capricor Therapeutics, Caribou Biosciences, Repligen and Arrowhead Pharmaceuticals.

Primary themes: clinical trial results, business development and venture financing.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Wed, 07 Oct 2026 07:18:06 -0700 SOZO Intution SOZO Intution 373 Featuring Capricor Therapeutics, Caribou Biosciences, Repligen and Arrowhead Pharmaceuticals.

Primary themes: clinical trial results, business development and venture financing.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 6th October 2026 5 5 Biotech Daily - 6th October 2026 full 44cd6f68-b7d8-4234-9b09-d9b70068faf7 https://share.transistor.fm/s/6598604d This digest covers key developments from Vaxcyte, AbbVie, Genmab, AstraZeneca, Summit Therapeutics and Eli Lilly, spanning pivotal Phase 3 readouts, a large equity transaction and regulatory and business-development updates across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> This digest covers key developments from Vaxcyte, AbbVie, Genmab, AstraZeneca, Summit Therapeutics and Eli Lilly, spanning pivotal Phase 3 readouts, a large equity transaction and regulatory and business-development updates across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Tue, 06 Oct 2026 06:39:56 -0700 SOZO Intution SOZO Intution 369 This digest covers key developments from Vaxcyte, AbbVie, Genmab, AstraZeneca, Summit Therapeutics and Eli Lilly, spanning pivotal Phase 3 readouts, a large equity transaction and regulatory and business-development updates across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 5th October 2026 4 4 Biotech Daily - 5th October 2026 full 4f81b64f-1052-4979-a649-aace8a65da5c https://share.transistor.fm/s/3f132cbf This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Mon, 05 Oct 2026 11:04:56 -0700 SOZO Intution SOZO Intution 388 This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector.

This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 2nd October 2026 3 3 Biotech Daily - 2nd October 2026 full 0a33dd35-f75c-4cbd-8969-45a82e47f57d https://share.transistor.fm/s/9da0e758 Key developments from Johnson & Johnson, Ultragenyx, Abogen Biosciences, and Daiichi Sankyo. 

]]> Key developments from Johnson & Johnson, Ultragenyx, Abogen Biosciences, and Daiichi Sankyo. 

]]> Fri, 02 Oct 2026 06:36:34 -0700 SOZO Intution SOZO Intution 375 Key developments from Johnson & Johnson, Ultragenyx, Abogen Biosciences, and Daiichi Sankyo. 

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - 1st October 2026 2 2 Biotech Daily - 1st October 2026 full e2c1db00-6241-4941-93a1-1e6e8761e1a9 https://share.transistor.fm/s/ce4204f0 This audio brief covers key developments from Boehringer Ingelheim, Roche, Fresenius and Sanofi, including clinical trial readouts, regulatory and product advancements, and corporate acquisitions.

It was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> This audio brief covers key developments from Boehringer Ingelheim, Roche, Fresenius and Sanofi, including clinical trial readouts, regulatory and product advancements, and corporate acquisitions.

It was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> Thu, 01 Oct 2026 07:15:43 -0700 SOZO Intution SOZO Intution 411 This audio brief covers key developments from Boehringer Ingelheim, Roche, Fresenius and Sanofi, including clinical trial readouts, regulatory and product advancements, and corporate acquisitions.

It was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

]]> biotechnology, pharmaceutical, life sciences No Biotech Daily - September 30, 2026 1 1 Biotech Daily - September 30, 2026 full 6f2e7491-99f4-4bca-9f18-3f051e159052 https://share.transistor.fm/s/e434e248 Full articles and references can be found: https://bobbyjim.substack.com/p/2026-09-30-biotech-daily-top-stories .

Visit sozointuition.com for personalized biotechnology news and insights.  

]]> Full articles and references can be found: https://bobbyjim.substack.com/p/2026-09-30-biotech-daily-top-stories .

Visit sozointuition.com for personalized biotechnology news and insights.  

]]> Wed, 30 Sep 2026 10:09:06 -0700 SOZO Intution SOZO Intution 400 Full articles and references can be found: https://bobbyjim.substack.com/p/2026-09-30-biotech-daily-top-stories .

Visit sozointuition.com for personalized biotechnology news and insights.  

]]> biotechnology, pharmaceutical, life sciences No